Document Detail


Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials.
MedLine Citation:
PMID:  22826359     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: In the Secondary Prevention of Small Subcortical Strokes (SPS3) trial, addition of clopidogrel to aspirin was associated with an unexpected increase in mortality in patients with lacunar strokes. We assessed the effect of the addition of clopidogrel to aspirin on mortality in a meta-analysis of published randomized trials.
METHODS: Randomized trials in which clopidogrel was added to aspirin in subjects with vascular disease or vascular risk factors were identified. Trials were restricted to those with a mean follow-up of ≥14 days in which both the combination of aspirin and clopidogrel was tested and mortality was reported.
RESULTS: Twelve trials included 90 934 participants (mean age, 63 years; 70% men; median follow-up, 1 year) with 6849 observed deaths. There was no significant increase in mortality with the combination therapy either in 4 short-term (14 days-3 months; OR, 0.93; 95% CI, 0.87-0.99) or in 7 long-term (>3 months; hazard ratio, 0.97; 95% CI, 0.91-1.04) trials after 1 long-term trial (the SPS3 trial) was excluded because of heterogeneity. Addition of clopidogrel was associated with an increase in fatal hemorrhage (OR, 1.35; 95% CI, 0.97-1.90) and a reduction in myocardial infarction (OR, 0.82; 95% CI, 0.74-0.91).
CONCLUSIONS: The addition of clopidogrel to aspirin has no overall effect on mortality. The SPS3 trial results are outliers, possibly because of a lower prevalence of coronary artery ischemia. Addition of clopidogrel to aspirin increases fatal bleeding and reduces myocardial infarction.
CLINICAL TRIAL REGISTRATION: URL: http//www.clinicaltrials.gov. Unique identifier: NCT00059306.
Authors:
Santiago Palacio; Robert G Hart; Lesly A Pearce; Oscar R Benavente
Related Documents :
18582629 - Acute heart failure syndromes and coronary perfusion.
12628729 - Detection of myocardial viability by contrast echocardiography in acute infarction pred...
11755279 - Magnetic resonance imaging demonstrates improved regional systolic wall motion and thic...
18287669 - The isolated, perfused pseudo-working heart model.
22163139 - Takotsubo cardiomyopathy associated with titration of duloxetine.
3812749 - Prolonged support of working rabbit hearts using fluosol-43 or erythrocyte media.
15227239 - Free-floating left atrial thrombus in hypertrophic cardiomyopathy: echocardiographic fi...
15476569 - Constrictive pericarditis versus restrictive cardiomyopathy: challenges in diagnosis an...
8589869 - Ventricular action potential and l-type calcium channel in infarct-induced hypertrophy ...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  43     ISSN:  1524-4628     ISO Abbreviation:  Stroke     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-24     Completed Date:  2012-10-04     Revised Date:  2014-04-01    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2157-62     Citation Subset:  IM    
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00059306
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aspirin / therapeutic use*
Cause of Death
Cerebral Hemorrhage / mortality
Data Interpretation, Statistical
Double-Blind Method
Drug Therapy, Combination
Female
Hemorrhage / mortality
Humans
Male
Middle Aged
Myocardial Infarction / mortality,  prevention & control
Platelet Aggregation Inhibitors / therapeutic use*
Randomized Controlled Trials as Topic
Ticlopidine / analogs & derivatives*,  therapeutic use
Treatment Outcome
Grant Support
ID/Acronym/Agency:
U01 NS038529/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Platelet Aggregation Inhibitors; A74586SNO7/clopidogrel; OM90ZUW7M1/Ticlopidine; R16CO5Y76E/Aspirin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of ...
Next Document:  High dosing of ?-tocopherol inhibits rat liver regeneration by modifying signal transducer and activ...